Biliary Tract Adenocarcinoma — Trials

Biliary Tract Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Academic and Community Cancer Research United
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03044587	Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer(NIFE)	completed	Phase 2	93	AIO-Studien-gGmbHOTHER	1	Oct 1, 2025	clinicaltrials
NCT00142480	Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer	completed	Phase 2	8	Massachusetts General HospitalOTHER	1	Apr 25, 2018